This book gathers the contributions of world-leading experts to provide a comprehensive overview of recent advances in gastro-intestinal oncology. In addition to analyzing scientific data, the book provides immediate applications for everyday clinical work. Among many developments examined are animal models for GI cancers, statistical models for predicting polyp recurrence after polypectomies, concepts for improving public awareness of GI cancers and basic science concepts poised to enter clinical use.
This book gathers the contributions of world-leading experts to provide a comprehensive overview of recent advances in gastro-intestinal oncology. In addition to analyzing scientific data, the book provides immediate applications for everyday clinical work. Among many developments examined are animal models for GI cancers, statistical models for predicting polyp recurrence after polypectomies, concepts for improving public awareness of GI cancers and basic science concepts poised to enter clinical use.
E. van Cutsem, University Hospital Leuven, Belgium / A.K. Rustgi, University of Pennsylvania, Philadelphia, PA, USA / W. Schmiegel, Ruhr University, Bochum, Germany / M. Zeitz, Charité Medical University, Berlin, Germany
Inhaltsangabe
List of principal contributors.- List of chairpersons.- Preface.- SECTION I: OESOPHAGEAL CANCER: AETIOLOGY, SCREENING AND TREATMENT.- 1. State-of-the art lecture: Of mice and men: mouse models for colon carcinogenesis.- 2. Surgical strategies in oesophageal cancer.- 3. Neoadjuvant therapy of oesophageal carcinoma and carcinoma of the gastro-oesophageal junction.- SECTION II: GASTRIC CANCER STANDARD AND NOVEL THERAPIES.- 4. Helicobacter pylori and risk of gastric cancer and lymphoma.- SECTION III: COLORECTAL CANCER: THE CONTROVERSY OF POLYP DEVELOPMENT - BEYOND APC?.- 5. State-of the -Art lecture: The Wnt pathway in tumorigenesis.- 6. Role of transforming growth factor beta and Wnt signalling pathways in colon cancer.- 7. Beyond the adenomatous polyposis coli era: alternative pathways to colorectal cancer.- 8. The molecular regulation of the malignant progression of human colorectal cancer.- SECTION IV: COLORECTAL CANCER: NEW SCREENING STRATEGIES FOR THE NEW MILLENNIUM.- 9. Impact
List of principal contributors.- List of chairpersons.- Preface.- SECTION I: OESOPHAGEAL CANCER: AETIOLOGY, SCREENING AND TREATMENT.- 1. State-of-the art lecture: Of mice and men: mouse models for colon carcinogenesis.- 2. Surgical strategies in oesophageal cancer.- 3. Neoadjuvant therapy of oesophageal carcinoma and carcinoma of the gastro-oesophageal junction.- SECTION II: GASTRIC CANCER STANDARD AND NOVEL THERAPIES.- 4. Helicobacter pylori and risk of gastric cancer and lymphoma.- SECTION III: COLORECTAL CANCER: THE CONTROVERSY OF POLYP DEVELOPMENT - BEYOND APC?.- 5. State-of the -Art lecture: The Wnt pathway in tumorigenesis.- 6. Role of transforming growth factor beta and Wnt signalling pathways in colon cancer.- 7. Beyond the adenomatous polyposis coli era: alternative pathways to colorectal cancer.- 8. The molecular regulation of the malignant progression of human colorectal cancer.- SECTION IV: COLORECTAL CANCER: NEW SCREENING STRATEGIES FOR THE NEW MILLENNIUM.- 9. Impact
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
